Kyverna Therapeutics Highlights Updated Miv-cel Data at EULAR Demonstrating Substantial Reduction in Disease Activity in ACPA-Positive, Treatment Refractory Rheumatoid Arthritis
This story is reported by Yahoo Finance. Read what other outlets are saying below, then open the original report for full details.